Hans Johnson, MBChB Mres MSc

Research Lead
Voy (Menwell LTD)
Bristol, United Kingdom

Disclosure information not submitted.

Presentation(s):

• SAT-709 - Digital Programme Engagement Substantially Enhances Weight Loss in Adults with Obesity Treated with GLP-1 Receptor Agonists: A Retrospective Analysis of 240,311 Participants

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• SUN-702 - Baseline Predictors of Real-World Weight Loss Outcomes with Injectable Semaglutide: Cohort Analysis of over 36,000 Individuals

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• SUN-703 - Comprehensive Digital Health Support Enhances GLP-1 Receptor Agonist Weight Loss Outcomes in Type 2 Diabetes

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF50-05 - Predictors of the Magnitude of Weight-Loss with Tirzepatide: A Cohort Study of over 80,000 Adults

  Monday, June 15, 2026
  2:15 PM - 2:30 PM CT